HEATHER STEWART: Open Payments
NPI 1700432846 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,749 in 140 payments from 16 companies in 2025. Trend: 2023 $39 · 2024 $2,320 · 2025 $2,749
Food & beverage: $2,665Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 42 | $712 |
| Janssen Biotech, Inc. | 20 | $448 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $252 |
| Madrigal Pharmaceuticals | 12 | $204 |
| Lilly USA, LLC | 6 | $149 |
| Gilead Sciences, Inc. | 7 | $147 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $143 |
| Intercept Pharmaceuticals, Inc. | 8 | $140 |
| Regeneron Healthcare Solutions, Inc. | 5 | $130 |
| Ipsen Biopharmaceuticals, Inc | 6 | $126 |
Products named: TREMFYA, RINVOQ, REZDIFFRA, LINZESS, ENTYVIO, DUPIXENT, OMVOH, OCALIVA.
Industry payments across MO — which companies pay providers there.
